(Q35570978)

English

PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes

scientific article published on August 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

cervical intraepithelial neoplasia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Chris J L M Meijer

8

object named as

Meijer CJ

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

author name string

Rozendaal L

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Westerga J

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

van der Linden JC

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Walboomers JM

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Voorhorst FJ

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Risse EK

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Boon ME

7

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Journal of Clinical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

606-611

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Cytomorphologic correlates of human papillomavirus infection in the "normal" cervicovaginal smear

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

The ThinPrep Pap test. A review of clinical studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

The epidemiology of cervical carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Can papilloma virus testing be used to improve cervical cancer screening?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

NeoPath, Inc. NeoPath AutoPap 300 Automatic Pap Screener System

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Sensitivity of the AutoPap 300 QC System for cervical cytologic abnormalities. Biopsy data confirmation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Human papillomavirus testing in primary cervical screening.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Natural history of cervical neoplasia: consistent results obtained by an identification technique

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

The Papanicolaou test for cervical cancer detection. A triumph and a tragedy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Preventive Pap-smears: balancing costs, risks and benefits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

12 July 2018

Evaluation of the CytoRich slide preparation process.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

26 September 2018

Consequences of neural network technology for cervical screening: increase in diagnostic consistency and positive scores.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

26 September 2018

Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

26 September 2018

Cancer of the Uterine Cervix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762926

24 October 2018

A cohort study of cervical cancer screening in British Columbia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening errors in cervical cytologic screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Recommendations in aberrant findings of cytological studies of the cervix uteri]

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients with various types of human papillomavirus: covariation and diagnostic relevance of cytological findings in Papanicolaou smears

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials of the CytoRich specimen-preparation device for cervical cytology. Preliminary results

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stringent criteria for histological diagnosis of koilocytosis fail to eliminate overdiagnosis of human papillomavirus infection and cervical intraepithelial neoplasia grade 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An Australian trial of ThinPrep: a new cytopreparatory technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human papillomavirus—the most significant risk determinant of cervical intraepithelial neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Roche Image Analysis Systems, Inc

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oncometrics Imaging Corporation and Xillix Technologies Corporation. Use of the Cyto-Savant in quantitative cytology

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of monolayer preparations for cervical cytology: emphasis on suboptimal specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/11002764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JCP.53.8.606

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35570978&oldid=2043804083"